Artelo Biosciences, Inc.
ARTL
$1.04
$0.010.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.83M | -9.12M | -10.44M | -9.60M | -9.29M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 569.00K | 455.00K | 367.00K | 293.00K | 419.00K |
| Change in Net Operating Assets | 907.00K | 287.00K | 668.00K | 348.00K | 663.00K |
| Cash from Operations | -8.35M | -8.38M | -9.40M | -8.96M | -8.21M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.77M | 10.01M | 3.93M | 2.58M | 3.51M |
| Cash from Investing | 7.77M | 10.01M | 3.93M | 2.58M | 3.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 112.00K | 87.00K | 622.00K | 622.00K | 567.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 112.00K | 87.00K | 622.00K | 622.00K | 567.00K |
| Foreign Exchange rate Adjustments | -8.00K | 0.00 | 15.00K | 43.00K | 60.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -477.00K | 1.72M | -4.84M | -5.72M | -4.07M |